March 30, 2020
Advance Online
Advance Online
Taltz® Receives Pediatric Indication
FDA Approves Taltz® for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
FDA Approves Taltz® for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.